- STAT+: Pharmalittle: We’re reading about Lilly and Pfizer obesity drug data, Roche and J&J deals, and moreLilly disclosed new data that provide more details on the safety and tolerability of its next-generation obesity drug retatrutideSTAT · 1mo ago↗ source
- STAT+: J&J spends $1 billion to enter KRAS race for cancer treatmentsJohnson & Johnson said it will purchase the startup Firefly Bio for $1 billion in an effort to expand its work in the suddenly buzzy field of KRAS inhibitors.STAT · 1mo ago↗ source
- Major readouts from the annual diabetes conferenceWhy "Schedule F" matters, the Ebola outbreak response, and more health news from Morning RoundsSTAT · 1mo ago↗ source